METHODS: In this retrospective study, 71 PD subjects (21 with normal cognition; 29 with cognitive impairment (PD-MCI); 21 with dementia (PDD)) and 26 healthy controls were included. All participants underwent neuromelanin-sensitive magnetic resonance imaging (NM-MRI) and diffusion tensor image scanning on a 3.0 T scanner. The brain glymphatic function was measured using diffusion along the perivascular space (ALPS) index, while LC degeneration was estimated using the NM contrast-to-noise ratio of LC (CNRLC).
RESULTS: The ALPS index was significantly lower in both the whole PD group (P = 0.04) and the PDD subgroup (P = 0.02) when compared to the controls. Similarly, the CNRLC was lower in the whole PD group (P < 0.001) compared to the controls. In the PD group, a positive correlation was found between the ALPS index and both the Montreal Cognitive Assessment (MoCA) score (r = 0.36; P = 0.002) and CNRLC (r = 0.26; P = 0.03). Mediation analysis demonstrated that the ALPS index acted as a significant mediator between CNRLC and the MoCA score in PD subjects.
CONCLUSIONS: The ALPS index, a neuroimaging marker of glymphatic function, serves as a mediator between LC degeneration and cognitive function in PD.
方法:在这项回顾性研究中,包括71名PD受试者(21名认知正常;29名认知障碍(PD-MCI);21名痴呆(PDD))和26名健康对照。所有参与者在3.0T扫描仪上接受了神经黑色素敏感磁共振成像(NM-MRI)和扩散张量图像扫描。使用沿血管周围间隙扩散(ALPS)指数测量脑淋巴功能,而LC变性是使用LC的NM对比噪声比(CNRLC)来估计的。
结果:与对照组相比,整个PD组(P=0.04)和PDD亚组(P=0.02)的ALPS指数均显着降低。同样,与对照组相比,整个PD组的CNRLC较低(P<0.001)。在PD组,ALPS指数与蒙特利尔认知评估(MoCA)评分(r=0.36;P=0.002)和CNRLC评分(r=0.26;P=0.03)呈正相关.中介分析表明,ALPS指数在PD受试者的CNRLC和MoCA评分之间起重要的中介作用。
结论:ALPS指数,一个神经成像标记的淋巴淋巴功能,在PD中充当LC变性和认知功能之间的中介。